Brind.

The FDA accepted the Biologics License Application (BLA) for a DMD therapy developed by a company led by John Cox.

1 report, 1 independent Updated Jul 22
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 1 outlet

The FDA accepted the Biologics License Application (BLA) for a DMD therapy developed by a company led by John Cox.

Who's involved

What this event is mainly about

Keep exploring

The entities involved

Coverage

Newest first; wire copies grouped